how does semaglutide affect the brain as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Ever wonder what Semaglutide is
Description
In the STEP trials, participants taking semaglutide lost significantly more weight than those on placebo, with weight loss continuing for the full duration of treatment
It mimics GLP-1 to suppress appetite and slow digestion, leading to better results (average ~15% body weight loss) than older drugs
Funding This work was supported by the National Natural Science Foundation of China [grant numbers 82470907, 82270880, and 82400944] Data availability All data supporting the findings of this study are available in the manuscript and supplementary materials
If you're unsure where to start, talk to one of our online GPs at Pocket Lab
Use a measured water bottle so you can monitor your intake as the day goes on
